newsfilter
← Latest News
GlobeNewswire·

China SXT Pharmaceuticals, Inc. Announces Share Re-classification

  • China SXT Pharmaceutics, Inc. (NASDAQ: SXTC) will begin trading Class A Ordinary Shares on The Nasdaq Stock Market under the symbol "SXTC" upon market opening on March 24, 2026.
  • Shareholders approved a dual-class share structure on July 28, 2025, creating unlimited Class B Ordinary Shares with 50 votes per share & designating existing shares as Class A Ordinary Shares with no par value.
  • The share re-classification became effective after filing the Amended & Restated Memorandum & Articles of Association with the British Virgin Islands Companies Registry.
  • Shares held through banks, brokers, or nominees will be automatically adjusted to reflect the new structure, with inquiries directed to brokers or transfer agent Transhare Corporation at +1 303-662-1122.
  • The company, founded in 2005 & headquartered in Taizhou City, Jiangsu Province, China, focuses on researching, developing, manufacturing, marketing, & selling Traditional Chinese Medicine Pieces & TCM Homologous Supplements.